Navigation Links
Statement of Robert Jarvik, MD, President and CEO of Jarvik Heart, Inc. Regarding the Lipitor DTC Advertisements
Date:2/26/2008

NEW YORK, Feb. 26 /PRNewswire/ -- The following is a statement being issued by Robert Jarvik, MD:

A lifetime career in heart disease

I remain deeply committed to alleviating suffering from heart disease, and I assure the public, from the bottom of my heart, that I have been sincere and honest in my role as Lipitor spokesman. The record needs to show that the ad campaign Pfizer tastefully presented to the public, using beautiful natural settings and high tech modern architecture, fairly represents me as a world recognized heart expert.

As spokesman for Lipitor, I have been an advocate of preventive medicine in addition to my work with the Jarvik 2000 Heart, which has rescued people from death and sustained a patient with a normal, mobile lifestyle for seven and a half years -- the longest in the world. The Jarvik 2000 Heart is in clinical trials at 18 medical centers in the U.S., is fully approved for use in Europe, and is also used in Australia and Japan.

Over 30 years ago, I invented an improvement to previous artificial hearts that extended the durability from weeks to years and enabled the first human application of any permanent total artificial heart -- the Jarvik 7. The more recent Jarvik 2000 is much less well known to the public than the Jarvik 7 was, but has been successfully miniaturized to the size of a c-cell battery with a belt-worn portable power system weighing only 2-1/2 lbs, compared to the four hundred pound console developed decades ago for the Jarvik 7. The improvement in patient quality of life is outstanding.

I am in fact a medical doctor; I am a world expert in mechanical heart technology; and I am an athletically fit man who takes care of his own health through diet and exercise, including frequent five mile runs.

Qualifications to endorse Lipitor

As a medical doctor who chose a career in artificial heart technology rather than clinical practice, I decided not to take an internship, whic
'/>"/>

SOURCE Jarvik Heart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Statement by Dr. Edward Jones, Chairman of Kidney Care Partners in Response to CMS Payment Bundling Report
2. Statement by Robert D. Foreman, President of The Kidney Care Council, Regarding the HHS Report to Congress A Design for a Bundled End Stage Renal Disease Prospective Payment System
3. Press Statement: Roche Affirms That Tamiflu(R) is in Ample Supply Nationwide
4. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
5. AHIP Statement on New York Attorney Generals Announcement
6. NCPA Statement on Economic Stimulus Package
7. Blue Cross of California Statement
8. Statement by James P. Firman, Chair Leadership Council of Aging Organizations (LCAO) on the Presidents FY2009 Budget Proposal
9. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
10. NCPA Statement in Response to President Bushs FY 2009 Budget Proposal
11. NCPA Statement on White House Campaign to End Teenage Prescription Drug Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...The National Minority Quality Forum (NMQF) today a... decision to develop a Health Insurer Code of Cond...to join the Forum in encouraging adoption and comp...icians and lawyers -- even politicians -- follow e...t and Chief Executive Officer of the Forum. "It,s ...
(Date:11/20/2008)...town Ballroom was transformed into a Cirque style ...ts filled the ballroom to help raise funds for one...,s Regional Medical Center. Generations of Nevada ...including Nevada Governor Jim Gibbons were in atte...ease, go to: http://www.prnewswire.com/mnr/stmary...
(Date:11/20/2008)...pported clean-water,campaign known as the TAP Pro...acturer, The Watergeeks Laboratories, will become ...he third year of this award-winning, life-saving,...hildren around the world. , Beginning Novem...nate a,percentage of the on-line retail price of ...
(Date:11/20/2008)...stectomy who undergo radiation therapy after immed...nstruction provides fewer long-term complications ...nd implant reconstruction, according to a study in...of Radiation Oncology*Biology*Physics , the offici... Radiology and Oncology., After undergoing a mast...
Breaking Medicine News(10 mins):Health News:National Minority Quality Forum Applauds AMA's Health Insurer Code of Conduct 2Health News:Photos: Nevada's Saint Mary's Regional Medical Center Raises $1.3 Million During Centennial Soiree 2Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 2Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 3Health News:Type of breast reconstruction impacts radiation therapy outcomes 2
...r have zeroed in on a crucial gene, thought to be ...istance// to long-term estrogen deprivation. The g...tors of breast cancer reappearance, and would enab...ntial treatment options. The research targeted ...
...tors and medical representatives needs no introduc...s begin// in the precincts of swank offices and bo...re given their ‘do or die’ sales targets. Propelle...ic medical rep gets to the bottom of the doctor’s ...
...seeing the food ads on television, says a study. I...re more vulnerable to it. Researchers from Liver...European Congress on Obesity in Budapest, said the...en aged between nine and 11 to a series of food an...
...rd flu is also struggling to ensure that poor coun...loped// to combat it. Since the first case was re...ported 74 deaths from the H5N1 strain in Indonesia...ld's total. But it has refused to share its samp...
Other Medicine News:Health News:Art of Establishing a Bond to Sell a Brand – Medical Reps Show the Wa 2Health News:Food Ads Prompts Children to Eat More 2Health News:Indonesia Struggles Against Bird Flu and the Drug Industry as Well 2
(Date:11/19/2008)...CHELLE, N.Y., Nov. 19 Biotech scie...gies to toxicology research to better understand t...f organ systems, reports Genetic Engineering &... interested in figuring out a new compound,s mecha...ive toxicology technique, according to the Novembe...
(Date:11/18/2008)..., November 19 NeuroDisco...vice provider and drug development Company,and S...: 4565), a leading,international biopharmaceutica...presenting further pivotal pre-clinical efficacy d...is a potential therapy for neuropathic pain and ha...
(Date:11/18/2008)...WNE, Va., Nov. 18 Forty...ered at a November national forum to consider cutt...lic health and national economy from outbreaks of ...nced today. , , Among those innovations: ,... American kitchen table that detects highly contag...
(Date:11/13/2008)...DFORD, Mass., Nov. 13 Ho... manufacturer and supplier of premium,diagnostics,...icated to,serving the healthcare needs of women, t...h-risk pivotal clinical trial. The Cervista HPV hi...in the U.S. and is expected to be,launched in the ...
Breaking Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4Jazz Pharmaceuticals Inc to Announce Third Quarter 2007 Financial Results on November 6 2007 1466 1Jazz Pharmaceuticals Inc to Announce Third Quarter 2007 Financial Results on November 6 2007 1466 2Emisphere Technologies Inc Appoints Gary Riley as Vice President Nonclinical Development 26 Applied Biology 1464 1Emisphere Technologies Inc Appoints Gary Riley as Vice President Nonclinical Development 26 Applied Biology 1464 2Emisphere Technologies Inc Appoints Gary Riley as Vice President Nonclinical Development 26 Applied Biology 1464 3Emisphere Technologies Inc Appoints Gary Riley as Vice President Nonclinical Development 26 Applied Biology 1464 4Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8 1462 1Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8 1462 2New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR 28R 29 28zolpidem tartrate extended release 2 633 1New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR 28R 29 28zolpidem tartrate extended release 2 633 2New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR 28R 29 28zolpidem tartrate extended release 2 633 3New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR 28R 29 28zolpidem tartrate extended release 2 633 4
...BARCELONA, Spain--(BUSINESS WIRE)--May 22, 2007 - ...e, Melbourne, Australia, on,Tuesday presented posi...E clinical trial at the EuroPCR meeting in Barcelo...se cardiac events and no,protocol-defined stent th... Endeavor(R) Resolute drug-eluting stent system wi...
...Sphingomab Shows Near-Complete Mitigation of Choro... DIEGO, May 22, 2007 /PRNewswire-FirstCall/ -- Lpa...ts against bioactive lipids,reported compelling p... human age-related macular degeneration (AMD). , T... the,Association of Research in Vision and Ophthal...
Other Medicine Technology:Medtronic Announces Positive Nine-Month Results for Endeavor,Resolute Next Generation Drug-Eluting Stent at EuroPCR 2Medtronic Announces Positive Nine-Month Results for Endeavor,Resolute Next Generation Drug-Eluting Stent at EuroPCR 3Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug,Candidate, Sphingomab 2Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug,Candidate, Sphingomab 3Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug,Candidate, Sphingomab 4
...n principle and the microplate separation. An unkn...ixed amount of DHEA-S conjugated with horse-radish...yclonal DHEA-S antiserum coated onto the wells. Af...hed to stop the competition reaction. Having added...
Inquire
...ct Rheumatoid Factor (RF) antibodies as well as t... the human serum without pre-diluting the patient ...articles uniformly suspended in a base, serum cont...e-usable plastic slide, 50 uL dispensters enough t...
The Diamedix immunosimplicity® Is- Rheumatoid Factor Test Kit is an EIA procedure intended for the quantitation of IgM antibodies to IgG antigen. The results are reported in IU/mL, traceable to t
Medicine Products: